| Issue Date | Title | Author(s) |
| 2014 | An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia | Huang, Xinfang; Du, Hui; Gu, Jieruo; Zhao, Dongbao; Jiang, Lindi; Li, Xinfu; Zuo, Xiaoxia; Liu, Yi; Li, Zhanguo; Li, Xiangpei; Zhu, Ping; Li, Juan; Zhang, Zhiyi; Huang, Anbin; Zhang, Yuanchao; Bao, Chunde |
| Jun-2020 | Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial | Su, Jinmei; Li, Mengtao; He, Lan; Zhao, Dongbao; Wan, Weiguo; Liu, Yi; Xu, Jianhua; Xu, Jian; Liu, Huaxiang; Jiang, Lindi; Wu, Huaxiang; Zuo, Xiaoxia; Huang, Cibo; Liu, Xiumei; Li, Fen; Zhang, Zhiyi; Liu, Xiangyuan; Dong, Lingli; Li, Tianwang; Chen, Haiying; Li, Jingyang; He, Dongyi; Lu, Xin; Huang, Anbin; Tao, Yi; Wang, Yanyan; Zhang, Zhuoli; Wei, Wei; Li, Xiaofeng; Zeng, Xiaofeng |
| Mar-2023 | Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study | Ye, Hua; Liu, Shengyun; Xu, Jian; Chai, Kexia; He, Dongyi; Fang, Yongfei; Xie, Qibing; Liu, Huaxiang; Liu, Ying; Hua, Bingzhu; Hu, Jiankang; Zhang, Zhiyi; Zhou, Mingxuan; Zhao, Dongbao; Li, Yan; Jiang, Zhenyu; Wang, Meimei; Li, Jingyang; Zhang, Zhuoli; Li, Xiaomei; Li, Yang; Sun, Erwei; Bi, Liqi; Wei, Wei; Tie, Ning; He, Lan; Huang, Xiangyang; Zhang, Yan; Huang, Qingchun; Wang, Xiaofei; Liu, Xiangyuan; Li, Jing; Su, Yin |
| 2019 | Efficacy and Safety of Loxoprofen Hydrogel TransdermalPatch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial | Zhao, Dongbao; Chen, Zhiwei; Hu, Shaoxian; Lin, Jianhao; Shao, Zengwu; Wang, Guochun; Xiao, Weiguo; Zheng, Yi; Zhang, Zhiyi; Shi, Yeqing; Li, Zhanguo |
| 2015 | Feasibility and Influential Factors in Performing Self-Evaluation of DAS28 with Smart System of Disease Management (SSDM) By RA Patient in China | Rong, Mu; Xiao, Fei; Li, Chun; Guan, Jianlong; Shen, Yan; Zhao, Dongbao; Xu, Xia; Jiang, Lindi; Chen, Huiyong; Su, Li; Jia, Yuhua; Zhang, Li; Liu, Yuan; Li, Zhan-Guo |
| 2013 | A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23 | Li, Yongzhe; Zhang, Kunlin; Chen, Hua; Sun, Fei; Xu, Juanjuan; Wu, Ziyan; Li, Ping; Zhang, Liuyan; Du, Yang; Luan, Haixia; Li, Xi; Wu, Lijun; Li, Hongbin; Wu, Huaxiang; Li, Xiangpei; Li, Xiaomei; Zhang, Xiao; Gong, Lu; Dai, Lie; Sun, Lingyun; Zuo, Xiaoxia; Xu, Jianhua; Gong, Huiping; Li, Zhijun; Tong, Shengquan; Wu, Min; Li, Xiaofeng; Xiao, Weiguo; Wang, Guochun; Zhu, Ping; Shen, Min; Liu, Shengyun; Zhao, Dongbao; Liu, Wei; Wang, Yi; Huang, Cibo; Jiang, Quan; Liu, Guijian; Liu, Bin; Hu, Shaoxian; Zhang, Wen; Zhang, Zhuoli; You, Xin; Li, Mengtao; Hao, |
| 2018 | Pattern Shift and Influential Factors in Promoting Treat-to-Target (T2T) for Follow-up RA Patients with a Rheumatologist-Patient Interactive Smart System of Disease Management (SSDM): A Cohort Study from China | Mu, Rong; Li, Chun; Yang, Jing; Wei, Hua; Huang, Jianlin; Fan, Wenqiang; Wang, Yongfu; Wang, Hongzhi; Zou, Jinmei; Shi, Xiaofei; Xin, Xiafei; Wu, Jianhong; Li, Fen; Li, Shouxin; Yang, Huiqin; Zhang, Anbing; Zhao, Dongbao; He, Jinchang; Zhang, Junli; Li, Luo; Ji, Peng; Rong, Xiaofeng; Jiang, Fong; Wang, Ling; Jia, Yuhua; Xiao, Fei; Li, Zhan-Guo |
| 2013 | Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus | Zhang, Xuewu; Zhang, Fengchun; Wu, Donghai; Bao, Chunde; Zhu, Ping; Zhang, Xiao; Huang, Cibo; He, DongYi; Tao, Yi; Fang, Yongfei; Gu, Jieruo; Wu, Huaxiang; Sun, Lingyun; Yang, Xiuyan; Huang, Feng; Xu, Huji; Zhao, Dongbao; Zhang, Miaojia; Zheng, Yi; Li, Zhanguo |
